Stallion India Fluorochemicals IPO Listing: Stallion India Fluorochemicals shares are set to make their debut in the Indian stock market today. The initial public offering (IPO) of Stallion India ...

Beeline Capital Advisors Pvt Ltd is the book running lead manager of the Solarium Green IPO, while Link Intime India Private Ltd is the registrar for the issue.The market maker for Solarium Green ...

A good amount of retail investor ownership and a share price north of $1,000 makes this brand-name company the most-logical candidate to announce a stock split.

MORGANTOWN, W. Va.--(BUSINESS WIRE)--Infinity Natural Resources, Inc. (“Infinity”) (NYSE: INR) announced today that Infinity President and CEO Zack Arnold and EVP and CFO David Sproule will be joined ...

In a similar challenge to an IPO in 2023, environmental law group ClientEarth applied for a judicial review after the FCA approved oil producer Ithaca Energy's flotation, but the High Court denied ...

Shein is reportedly poised to chop its valuation by billions of dollars for its anticipated London listing after President Trump ended a trade loophole that allowed the Chinese fast-fashion firm ...

Apple's board of directors has declared five stock splits since its 1980 initial public offering (IPO). The stock had several 2-for-1 splits between 1987 and 2005 (June 1987, June 2000 ...

Business news Highlights (February 3): From all the latest IPO action to buzz around upcoming Income Tax Bill, we are tracking all the news, views from the world of finance. For those who are ...

The initial public offering (IPO) of Hexaware Technologies shall open for bidding on Wednesday, February 12. The IT solutions player is offering its shares in the range of Rs 675-708 apiece.

We built our IPO process in partnership with the investment banking community, ensuring that they have the control and information they need to successfully open your IPO. Nasdaq’s best-in-class ...

[an IPO is] the plan.” Mistral, which Mensch launched in 2023 alongside former researchers from Google’s DeepMind and Meta, is often described as Europe’s answer to U.S. incumbents like OpenAI.

Odyssey Therapeutics and Sionna Therapeutics have filed IPO paperwork, swelling the pack of startups that will provide an early look at how receptive public investors could be to biotech listings ...